annual CAPEX:
$4.05M+$569.00K(+16.34%)Summary
- As of today (September 10, 2025), EYPT annual capital expenditures is $4.05 million, with the most recent change of +$569.00 thousand (+16.34%) on December 31, 2024.
- During the last 3 years, EYPT annual CAPEX has risen by +$3.90 million (+2497.44%).
- EYPT annual CAPEX is now at all-time high.
Performance
EYPT CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CAPEX:
$1.22M+$944.00K(+342.03%)Summary
- As of today (September 10, 2025), EYPT quarterly capital expenditures is $1.22 million, with the most recent change of +$944.00 thousand (+342.03%) on June 30, 2025.
- Over the past year, EYPT quarterly CAPEX has increased by +$320.00 thousand (+35.56%).
- EYPT quarterly CAPEX is now -29.07% below its all-time high of $1.72 million, reached on September 30, 2023.
Performance
EYPT quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CAPEX:
$3.45M+$320.00K(+10.21%)Summary
- As of today (September 10, 2025), EYPT TTM capital expenditures is $3.45 million, with the most recent change of +$320.00 thousand (+10.21%) on June 30, 2025.
- Over the past year, EYPT TTM CAPEX has dropped by -$1.24 million (-26.46%).
- EYPT TTM CAPEX is now -26.46% below its all-time high of $4.70 million, reached on June 30, 2024.
Performance
EYPT TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EYPT CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +16.3% | +35.6% | -26.5% |
| 3 y3 years | +2497.4% | +459.6% | +593.6% |
| 5 y5 years | +1802.3% | +4592.3% | +7095.8% |
EYPT CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +2497.4% | -29.1% | +459.6% | -26.5% | +593.6% |
| 5 y | 5-year | at high | +2497.4% | -29.1% | >+9999.0% | -26.5% | +7095.8% |
| alltime | all time | at high | >+9999.0% | -29.1% | >+9999.0% | -26.5% | >+9999.0% |
EYPT CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $1.22M(+342.0%) | $3.45M(+10.2%) |
| Mar 2025 | - | $276.00K(-28.1%) | $3.13M(-22.7%) |
| Dec 2024 | $4.05M(+16.3%) | $384.00K(-75.6%) | $4.05M(-11.0%) |
| Sep 2024 | - | $1.57M(+74.9%) | $4.55M(-3.1%) |
| Jun 2024 | - | $900.00K(-24.6%) | $4.70M(+12.0%) |
| Mar 2024 | - | $1.19M(+35.2%) | $4.19M(+20.4%) |
| Dec 2023 | $3.48M(+62.0%) | $883.00K(-48.7%) | $3.48M(+9.4%) |
| Sep 2023 | - | $1.72M(+334.3%) | $3.19M(+19.6%) |
| Jun 2023 | - | $396.00K(-18.2%) | $2.66M(+7.2%) |
| Mar 2023 | - | $484.00K(-17.3%) | $2.48M(+15.6%) |
| Dec 2022 | $2.15M(+1278.2%) | $585.00K(-51.2%) | $2.15M(+37.4%) |
| Sep 2022 | - | $1.20M(+449.5%) | $1.56M(+214.3%) |
| Jun 2022 | - | $218.00K(+46.3%) | $498.00K(+63.3%) |
| Mar 2022 | - | $149.00K(>+9900.0%) | $305.00K(+95.5%) |
| Dec 2021 | $156.00K(-56.9%) | $0.00(-100.0%) | $156.00K(-55.2%) |
| Sep 2021 | - | $131.00K(+424.0%) | $348.00K(+0.9%) |
| Jun 2021 | - | $25.00K(>+9900.0%) | $345.00K(-0.3%) |
| Mar 2021 | - | $0.00(-100.0%) | $346.00K(-4.4%) |
| Dec 2020 | $362.00K(+70.0%) | $192.00K(+50.0%) | $362.00K(+105.7%) |
| Sep 2020 | - | $128.00K(+392.3%) | $176.00K(+266.7%) |
| Jun 2020 | - | $26.00K(+62.5%) | $48.00K(+2.1%) |
| Mar 2020 | - | $16.00K(+166.7%) | $47.00K(-77.9%) |
| Dec 2019 | $213.00K(+61.4%) | $6000.00(>+9900.0%) | $213.00K(+2.9%) |
| Sep 2019 | - | $0.00(-100.0%) | $207.00K(0.0%) |
| Jun 2019 | - | $25.00K(-86.3%) | $207.00K(+13.7%) |
| Mar 2019 | - | $182.00K(+44.4%) | $182.00K(+23.8%) |
| Dec 2018 | $132.00K(-10.2%) | - | - |
| Jun 2017 | $147.00K(+30.1%) | $126.00K(+687.5%) | $147.00K(+119.4%) |
| Mar 2017 | - | $16.00K(+220.0%) | $67.00K(-18.3%) |
| Dec 2016 | - | $5000.00(>+9900.0%) | $82.00K(-19.6%) |
| Sep 2016 | - | $0.00(-100.0%) | $102.00K(-9.7%) |
| Jun 2016 | $113.00K(-29.8%) | $46.00K(+48.4%) | $113.00K(-28.0%) |
| Mar 2016 | - | $31.00K(+24.0%) | $157.00K(-7.1%) |
| Dec 2015 | - | $25.00K(+127.3%) | $169.00K(+1.8%) |
| Sep 2015 | - | $11.00K(-87.8%) | $166.00K(+3.1%) |
| Jun 2015 | $161.00K | $90.00K(+109.3%) | $161.00K(-34.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2015 | - | $43.00K(+95.5%) | $244.00K(-4.3%) |
| Dec 2014 | - | $22.00K(+266.7%) | $255.00K(+3.7%) |
| Sep 2014 | - | $6000.00(-96.5%) | $246.00K(-0.8%) |
| Jun 2014 | $248.00K(+264.7%) | $173.00K(+220.4%) | $248.00K(+163.8%) |
| Mar 2014 | - | $54.00K(+315.4%) | $94.00K(+77.4%) |
| Dec 2013 | - | $13.00K(+62.5%) | $53.00K(-26.4%) |
| Sep 2013 | - | $8000.00(-57.9%) | $72.00K(+5.9%) |
| Jun 2013 | $68.00K(-83.2%) | $19.00K(+46.2%) | $68.00K(+23.6%) |
| Mar 2013 | - | $13.00K(-59.4%) | $55.00K(-9.8%) |
| Dec 2012 | - | $32.00K(+700.0%) | $61.00K(-67.6%) |
| Sep 2012 | - | $4000.00(-33.3%) | $188.00K(-53.6%) |
| Jun 2012 | $405.00K(+204.5%) | $6000.00(-68.4%) | $405.00K(-12.7%) |
| Mar 2012 | - | $19.00K(-88.1%) | $464.00K(+2.2%) |
| Dec 2011 | - | $159.00K(-28.1%) | $454.00K(+31.6%) |
| Sep 2011 | - | $221.00K(+240.0%) | $345.00K(+159.4%) |
| Jun 2011 | $133.00K(+786.7%) | $65.00K(+622.2%) | $133.00K(+60.2%) |
| Mar 2011 | - | $9000.00(-82.0%) | $83.00K(+12.2%) |
| Dec 2010 | - | $50.00K(+455.6%) | $74.00K(+208.3%) |
| Sep 2010 | - | $9000.00(-40.0%) | $24.00K(+60.0%) |
| Jun 2010 | $15.00K(-92.3%) | $15.00K(>+9900.0%) | $15.00K(-28.6%) |
| Mar 2010 | - | $0.00(0.0%) | $21.00K(-46.2%) |
| Dec 2009 | - | $0.00(0.0%) | $39.00K(-55.7%) |
| Sep 2009 | - | $0.00(-100.0%) | $88.00K(-54.9%) |
| Jun 2009 | $195.00K(-28.3%) | $21.00K(+16.7%) | $195.00K(-37.7%) |
| Mar 2009 | - | $18.00K(-63.3%) | $313.00K(-7.7%) |
| Dec 2008 | - | $49.00K(-54.2%) | $339.00K(+14.1%) |
| Sep 2008 | - | $107.00K(-23.0%) | $297.00K(+9.2%) |
| Jun 2008 | $272.00K(+253.2%) | $139.00K(+215.9%) | $272.00K(+104.5%) |
| Mar 2008 | - | $44.00K(+528.6%) | $133.00K(+49.4%) |
| Dec 2007 | - | $7000.00(-91.5%) | $89.00K(+8.5%) |
| Sep 2007 | - | $82.00K | $82.00K |
| Jun 2007 | $77.00K(-91.8%) | - | - |
| Jun 2006 | $941.00K(-63.7%) | - | - |
| Jun 2005 | $2.59M(+607.0%) | - | - |
| Jun 2004 | $366.30K(+928.9%) | - | - |
| Jun 2003 | $35.60K(-37.7%) | - | - |
| Jun 2001 | $57.10K | - | - |
FAQ
- What is EyePoint Pharmaceuticals, Inc. annual capital expenditures?
- What is the all time high annual CAPEX for EyePoint Pharmaceuticals, Inc.?
- What is EyePoint Pharmaceuticals, Inc. annual CAPEX year-on-year change?
- What is EyePoint Pharmaceuticals, Inc. quarterly capital expenditures?
- What is the all time high quarterly CAPEX for EyePoint Pharmaceuticals, Inc.?
- What is EyePoint Pharmaceuticals, Inc. quarterly CAPEX year-on-year change?
- What is EyePoint Pharmaceuticals, Inc. TTM capital expenditures?
- What is the all time high TTM CAPEX for EyePoint Pharmaceuticals, Inc.?
- What is EyePoint Pharmaceuticals, Inc. TTM CAPEX year-on-year change?
What is EyePoint Pharmaceuticals, Inc. annual capital expenditures?
The current annual CAPEX of EYPT is $4.05M
What is the all time high annual CAPEX for EyePoint Pharmaceuticals, Inc.?
EyePoint Pharmaceuticals, Inc. all-time high annual capital expenditures is $4.05M
What is EyePoint Pharmaceuticals, Inc. annual CAPEX year-on-year change?
Over the past year, EYPT annual capital expenditures has changed by +$569.00K (+16.34%)
What is EyePoint Pharmaceuticals, Inc. quarterly capital expenditures?
The current quarterly CAPEX of EYPT is $1.22M
What is the all time high quarterly CAPEX for EyePoint Pharmaceuticals, Inc.?
EyePoint Pharmaceuticals, Inc. all-time high quarterly capital expenditures is $1.72M
What is EyePoint Pharmaceuticals, Inc. quarterly CAPEX year-on-year change?
Over the past year, EYPT quarterly capital expenditures has changed by +$320.00K (+35.56%)
What is EyePoint Pharmaceuticals, Inc. TTM capital expenditures?
The current TTM CAPEX of EYPT is $3.45M
What is the all time high TTM CAPEX for EyePoint Pharmaceuticals, Inc.?
EyePoint Pharmaceuticals, Inc. all-time high TTM capital expenditures is $4.70M
What is EyePoint Pharmaceuticals, Inc. TTM CAPEX year-on-year change?
Over the past year, EYPT TTM capital expenditures has changed by -$1.24M (-26.46%)